Carlos F. Salinas, DMD (April 9, 1941–January 14, 2015)

Y. Lacassie

DOI: https://doi.org/10.1002/ajmg.a.37025

2015-05-01

Abstract:

What problem does this paper attempt to address?

Predictors of functioning in treatment-resistant schizophrenia: the role of negative symptoms and neurocognition

Yanhui Li,Mei San Ang,Jie Yin Yee,Yuen Mei See,Jimmy Lee

DOI: https://doi.org/10.3389/fpsyt.2024.1444843

2024-08-23

Abstract:Introduction: Predictors of functioning are well-studied in schizophrenia, but much less so in treatment-resistant schizophrenia (TRS). In this study, we aim to investigate contributions of schizophrenia symptom domains and neurocognition to predict functioning in a TRS population (n = 146). Methods: Participants were assessed on the Positive and Negative Syndrome Scale (PANSS), to calculate scores for five symptom factors (Positive, Negative, Cognitive, Depressive and Hostility) and two negative symptom constructs (Diminished Expressivity (DE), and Social Anhedonia (SA) as part of the Motivation and Pleasure-related dimension), based on a previously validated model, modified in accordance with EPA guidelines on negative symptoms assessment. Neurocognition was assessed with symbol coding and digit sequencing tasks from the Brief Assessment of Cognition in Schizophrenia (BACS). Functioning was assessed with the Social and Occupational Functioning Assessment Scale (SOFAS), employment status and World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0). Multiple regression analyses were performed on psychopathology scores and BACS scores against all three measures of functioning, controlling for age and sex. For WHODAS, regression with PANSS scores of significant symptom factors were also performed. Results: A lower severity of negative symptoms in the SA dimension was the strongest predictor of higher functioning across all three functioning measures. Neurocognition, in particular processing speed and attention assessed on the symbol coding task, predicted employment. A lower severity of somatic concerns and depressive symptoms was associated with lesser self-reported disability on WHODAS. Discussion: This study represents a first attempt at elucidating significant predictors of functioning in TRS. We highlight negative symptoms and neurocognition as important treatment targets to improve functioning in TRS, consistent with previous studies in general schizophrenia.
Increased Sensitivity to Effort and Perception of Effort in People with Schizophrenia

Adam J Culbreth,Vikram S Chib,Safa S Riaz,Sanjay G Manohar,Masud Husain,James A Waltz,James M Gold

DOI: https://doi.org/10.1093/schbul/sbae162

2024-09-21

Abstract:Objective: Motivational deficits in schizophrenia are proposed to be attributable in part to abnormal effort-cost computations, calculations weighing the costs vs. the benefits of actions. Several reports have shown that people with schizophrenia display a reduced willingness to exert effort for monetary rewards when compared to controls. The primary goal of the current study was to further characterize reduced willingness to exert effort in schizophrenia by determining whether reduced willingness reflects (1) reduced sensitivity to reward, (2) increased sensitivity to effort, or (3) a combination of both. Design: We assessed effort-cost decision-making in 30 controls and 30 people with schizophrenia, using 2 separate experimental tasks. Critically, one paradigm allowed for independent estimation of effects of reward and effort sensitivity on choice behavior. The other task isolated effort sensitivity by measuring effort in the absence of reward. Clinical interviews and self-report questionnaires were administered to people with schizophrenia to determine negative symptom severity. Results: Across both tasks, we found evidence for reduced willingness to exert effort in people with schizophrenia compared to controls. Further, in both paradigms reduced willingness to exert effort was driven by increased sensitivity to effort in people with schizophrenia compared to controls. In contrast, measures of reward sensitivity did not significantly differ between groups. Surprisingly, we did not find correlations between task variables and measures of negative symptom severity. Conclusions and relevance: These findings further specify prior work by identifying a specific contributory role for increased effort sensitivity in effort-cost decision-making deficits in schizophrenia.
Association between treatment resistance and cognitive function in schizophrenia

Jiaqian Sun,Jie Yin Yee,Yuen Mei See,Charmaine Tang,Shushan Zheng,Boon Tat Ng,Jimmy Lee

DOI: https://doi.org/10.4103/singaporemedj.SMJ-2024-143

2024-10-01

Abstract:Introduction: Treatment-resistant schizophrenia (TRS) affects around 30% of individuals with schizophrenia. About half of the patients with TRS who are treated with clozapine do not show a meaningful clinical response, that is, clozapine resistance. To date, the relationship between cognitive function and treatment response categories is not entirely clear. This study evaluated the cognitive performance across subgroups stratified by treatment response, and we hypothesised that cognitive impairment increases with increased treatment resistance. Methods: This study was conducted at the Institute of Mental Health, Singapore, and included healthy controls and people with schizophrenia categorised into these groups: antipsychotic-responsive schizophrenia (ARS), clozapine-responsive TRS (TRS-CR) and clozapine-resistant TRS (ultra-treatment-resistant schizophrenia [UTRS]). Cognitive function was assessed using the Brief Assessment of Cognition-Short Form. Symptoms were measured with the Positive and Negative Syndrome Scale (PANSS). The planned statistical analyses included adjustments for covariates such as age, sex, PANSS scores and antipsychotic dose, which might affect cognitive function. Results: There were significant differences in overall cognitive performance between the groups: ARS had the least impairment, followed by TRS-CR and UTRS. Antipsychotic dose, and PANSS negative and disorganisation/cognitive factors were significant predictors of overall cognitive function in all patient groups. Conclusions: Our study found differences in cognitive function that aligned with levels of treatment resistance: the greater the degree of treatment resistance, the poorer the cognitive function. Interventions to improve negative and disorganisation symptoms might be effective to enhance the cognitive function and treatment outcomes in schizophrenia.
Reward-dependent modulation of working memory is associated with negative symptoms in schizophrenia

Oliver M Hager,Matthias Kirschner,Martin Bischof,Matthias N Hartmann-Riemer,Agne Kluge,Erich Seifritz,Philippe N Tobler,Stefan Kaiser

DOI: https://doi.org/10.1016/j.schres.2015.08.024

Abstract:The negative symptoms of schizophrenia have been associated with altered neural activity during both reward processing and cognitive processing. Even though increasing evidence suggests a strong interaction between these two domains, it has not been studied in relation to negative symptoms. To elucidate neural mechanisms of the reward-cognition interaction, we applied a letter variant of the n-back working memory task and varied the financial incentives for performance. In the interaction contrast, we found a significantly activated cluster in the rostral anterior cingulate cortex (ACC), the middle frontal gyrus, and the bilateral superior frontal gyrus. The interaction did not differ significantly between the patient group and a healthy control group, suggesting that patients with schizophrenia are on average able to integrate reward information and utilize this information to maximize cognitive performance. However within the patient group, we found a significant inverse correlation of ACC activity with the factor diminished expression. This finding is consistent with the model that a lack of available cognitive resources leads to diminished expression. We therefore argue that patients with diminished expression have difficulties in recruiting additional cognitive resources (as implemented in the ACC) in response to an anticipated reward. Due to this lack of cognitive resources, less processing capacity is available for effective expression, resulting in diminished expressive behavior.
Dampened motivation in schizophrenia: evidence from a novel effort-based decision-making task in social scenarios

Yu-Xin Shao,Ling-Ling Wang,Han-Yu Zhou,Zheng-Hui Yi,Shuai Liu,Chao Yan

DOI: https://doi.org/10.1007/s00406-024-01761-8

2024-02-29

European Archives of Psychiatry and Clinical Neuroscience

Abstract:Apathy represents a significant manifestation of negative symptoms within individuals diagnosed with schizophrenia (SCZ) and exerts a profound impact on their social relationships. However, the specific implications of this motivational deficit in social scenarios have yet to be fully elucidated. The present study aimed to examine effort-based decision-making in social scenarios and its relation to apathy symptoms in SCZ patients. We initially recruited a group of 50 healthy participants (16 males) to assess the validity of the paradigm. Subsequently, we recruited 45 individuals diagnosed with SCZ (24 males) and 49 demographically-matched healthy controls (HC, 25 males) for the main study. The Mock Job Interview Task was developed to measure effort-based decision-making in social scenarios. The proportion of hard-task choice and a range of subjective ratings were obtained to examine potential between-group differences. SCZ patients were less likely than HC to choose the hard task with strict interviewers, and this group difference was significant when the hard-task reward value was medium and high. More severe apathy symptoms were significantly correlated with an overall reduced likelihood of making a hard-task choice. When dividing the jobs into two categories based on the levels of social engagement needed, SCZ patients were less willing to expend effort to pursue a potential offer for jobs requiring higher social engagement. Our findings indicated impaired effort-based decision-making in SCZ can be generalized from the monetary/nonsocial to a more ecologically social dimension. Our findings affirm the critical role of aberrant effort allocation on negative symptoms, and may facilitate the development of targeted clinical interventions.

psychiatry,clinical neurology
Implicit cognitive effort monitoring impairments are associated with expressive negative symptoms in schizophrenia

Tanya Tran,Michael J Spilka,Ivan Ruiz,Gregory P Strauss

DOI: https://doi.org/10.1016/j.schres.2022.07.006

Abstract:Negative symptoms are a strong predictor of functional impairment in schizophrenia (SZ). Unfortunately, mechanisms underlying negative symptoms are poorly understood and available treatments are minimally effective. The current study evaluated the novel hypothesis that negative symptoms are associated with an implicit cognitive effort monitoring impairment that manifests during tasks requiring sustained allocation of cognitive control. Outpatients with SZ (n = 33) and healthy controls (CN; n = 29) completed an adapted Demand Selection Task (DST) in which subjects made choices between pairs of cognitive tasks that were implicitly and then explicitly made discrepant in effort demands. The SZ group demonstrated a reduced probability of avoiding the high effort cognitive task in the implicit choice condition but were able to become effort avoidant when the demands of the task were made explicit. Implicit cognitive effort monitoring deficits were associated with greater severity of the expressivity dimension of negative symptoms, but not the motivation and pleasure dimension. The association between diminished expressivity and implicit cognitive effort monitoring deficits is interpreted in light of a novel cognitive resource depletion theory, whereby individuals with SZ may become less expressive due to difficulty implicitly monitoring ongoing cognitive effort exertion and dynamically adjusting effort expenditure as task demands fluctuate.
Different Lifestyles and their Impact on the Environment

P. Christensen

DOI: https://doi.org/10.1002/(SICI)1099-1719(199703)5:1<30::AID-SD59>3.0.CO;2-5

1997-03-01

Abstract:The transition to a sustainable society is happening too slowly. Although many changes have been introduced in public policies to ensure the greening of industry, these steps towards sustainability are insufficient unless individual households also contribute. This study tries to show that households have very different impacts on the environment. A difference in lifestyle, i.e. how we choose to live, be transported and choose our provisions, can have a dramatic impact on the environment. Based on life cycle assessment the environmental impacts from cradle to grave of different lifestyles have been calculated. The study shows that there are large differences among the analysed families. The 'American lifestyle 'family, which is very dependent on transport by car, lives in its own large house and eats a lot of meat, pollutes eight times as much as the analysed 'green' family. The study thus demonstrates that it is necessary to influence lifestyles as a logical next step in the transition to a sustainable society. © 1997 by John Wiley & Sons, Ltd. and ERP Environment Sustainable Development, Vol. 5, 30-35 (1997)
Shifting the focus toward rare variants in schizophrenia to close the gap from genotype to phenotype

M. Leonor Bustamante,Luisa Herrera,Pablo A. Gaspar,R. Nieto,Alejandro Maturana,M. J. Villar,Valeria Salinas,H. Silva

DOI: https://doi.org/10.1002/ajmg.b.32550

2017-06-14

Abstract:Schizophrenia (SZ) is a disorder with a high heritability and a complex architecture. Several dozen genetic variants have been identified as risk factors through genome‐wide association studies including large population‐based samples. However, the bulk of the risk cannot be accounted for by the genes associated to date. Rare mutations have been historically seen as relevant only for some infrequent, Mendelian forms of psychosis. Recent findings, however, show that the subset of patients that present a mutation with major effect is larger than expected. We discuss some of the molecular findings of these studies. SZ is clinically and genetically heterogeneous. To identify the genetic variation underlying the disorder, research should be focused on features that are more likely a product of genetic heterogeneity. Based on the phenotypical correlations with rare variants, cognition emerges as a relevant domain to study. Cognitive disturbances could be useful in selecting cases that have a higher probability of carrying deleterious mutations, as well as on the correct ascertainment of sporadic cases for the identification of de novo variants.
Relationship of Behavioural and Symptomatic Syndromes in Schizophrenia to Spatial Working Memory and Attentional Set-Shifting Ability

C Pantelis,CA Harvey,G Plant,E Fossey,P Maruff,GW Stuart,WJ Brewer,HE Nelson,TW Robbins,TRE Barnes

DOI: https://doi.org/10.1017/s0033291703001569

IF: 10.592

2004-01-01

Psychological Medicine

Abstract:Background. Behavioural syndromes (thought disturbance, social withdrawal, depressed behaviour and antisocial behaviour) offer a different perspective from that of symptomatic syndromes on the disability that may be associated with schizophrenia. Few studies have assessed their relationship with neuropsychological deficits. We hypothesized that these syndromes may represent behavioural manifestations of frontal-subcortical impairments, previously described in schizophrenia. Method. Long-stay inpatients (n=54) and community patients (n=43) with enduring schizophrenia were assessed, using measures of symptoms and behaviour and tests of executive functioning. The relationship between syndromes and neuropsychological function was assessed using multiple regression and logistic regression analyses. Results. Significant associations were found between performance on the spatial working memory task and the psychomotor poverty symptomatic syndrome, and between attentional set-shifting ability and both disorganization symptoms and the thought disturbance behavioural syndrome. These results were not explained by the effect of premorbid IQ, geographical location, length of illness or antipsychotic medication. Length of illness was an independent predictor of attentional set-shifting ability but not of working memory performance. Conclusion. The specific relationship between negative symptoms and spatial working memory is consistent with involvement of the dorsolateral prefrontal cortex. The associations between difficulty with set-shifting ability and both disorganization symptoms and behaviours may reflect inability to generalize a rule that had been learned and impaired ability to respond flexibly. The specific relationship of illness duration to set-shifting ability may suggest progressive impairment on some executive tasks. The nature of these relationships and their neurobiological and rehabilitation implications are considered.
Heterogeneity analysis of diffusion-weighted MRI for prediction and assessment of microstructural changes early after one cycle of induction chemotherapy in nasopharyngeal cancer patients

M. Beigi,A. Kazerooni,M. Safari,Marzieh Alamolhoda,M. S. Moghdam,S. Moghadam,H. Salighehrad,A. Ameri

DOI: https://doi.org/10.1007/s11547-017-0808-9

La radiologia medica

Abstract:
Failure of convulsive response in electroconvulsive therapy in a patient treated with acetazolamide (diamox); report of a case.

J. Ungerleider

DOI: https://doi.org/10.1176/ajp.115.1.81

IF: 17.7

American Journal of Psychiatry

Abstract:
S67. TREATMENT-RESISTANCE AFFECTS LONG-TERM COGNITIVE TRAJECTORIES IN SCHIZOPHRENIA: A LONGITUDINAL STUDY

Marco Spangaro,Marta Bosia,Margherita Bechi,Mariachiara Buonocore,Francesca Martini,Roberto Cavallaro

DOI: https://doi.org/10.1093/schbul/sbaa031.133

2020-04-01

Schizophrenia Bulletin

Abstract:Abstract Background Schizophrenia is a highly heterogeneous disorder, and despite extensive research progress approximately 30% of patients with schizophrenia show poor response to first-line antipsychotics, denoted as treatment-resistant schizophrenia (TRS). Meta-analytic evidence showed that clozapine is the most effective antipsychotic for TRS, although 40% of TRS patients do not respond even to clozapine (ultra-treatment-resistant schizophrenia -UTR). Recent studies indicated that TRS is neurobiologically and categorically distinct from treatment-responsive schizophrenia, being associated with elevated glutamate levels in the anterior cingulate cortex and unaltered striatal dopamine synthesis. Moreover, the striking majority of TRS patients do not respond to first-line antipsychotic therapy since disease onset and present more severe cognitive deficits since first episode of psychosis, further suggesting the presence of a distinct and more disrupted neurobiological substrate. It is widely known that cognitive impairment is a core feature of schizophrenia and determines a significant detrimental impact on long-term functional outcome, which represents the ultimate treatment goal. However, despite the central role of cognition in schizophrenia, to date no study has investigated longitudinal cognitive outcome among TRS patients. Based on these evidences, the aim of this study is to evaluate longitudinal cognitive trajectories in a sample of clinically stabilized patients with schizophrenia, stratified according to antipsychotic response. We hypothesized that treatment-resistance is associated with a more severe long-term cognitive decline. Methods We enrolled 93 patients with schizophrenia (DSM-V), stratified as follows: 32 first-line responders (FLR), 42 TRS and 19 UTR. Cognition was longitudinally assessed at baseline and at least after 6 years of follow-up (mean: 9.3±2.8 years) using the Brief Assessment of Cognition in Schizophrenia (BACS). From BACS subscores we calculated for each patient a Cognitive Index, as a measure of overall cognitive functioning. In order to quantify global cognitive functioning changes during the course of illness, we estimated effect size score for Cognitive Index using Cohen’s d. Finally, General linear Models (GLM) were performed with overall cognitive index effect size as dependent variable, treatment (FLR/TRS/UTR) as categorical variable and age, duration of illness and education as covariates. Results The first GLM (FLR vs TRS+UTR) showed a significant main effect of treatment (F=7.34, p=0.01), with worse cognitive outcome between resistant patients. Consistently, the second GLM (FLR/TRS/UTR) resulted significant as well (F=17.90, p<0.001), with UTR group showing worse cognitive trajectory (Fisher’s post-hoc: p<0.001, UTR Cognitive Index effect size = -0.7). Discussion This is the first study to longitudinally evaluate cognitive trajectories of patients with schizophrenia according to their antipsychotic response. We showed that treatment resistance is associated with a more severe cognitive decline, with worse outcome among UTR patients. These data suggest that greater severity of treatment resistance in schizophrenia is associated with greater cognitive impairment, possibly due to the presence of a distinct and more disrupted neurobiological substrate that affects both cognition and antipsychotic response. These findings further highlight the necessity of early individuation and tailored pharmacological treatment for TRS patients, in order to improve long-term clinical, cognitive and functional outcome.

psychiatry
Cognitive function changes with risperidone monotherapy and their relationship to psychotic symptoms in treatment-na?ve first-episode schizophrenia patients

胡茂林,宗小芬,唐劲松,廖艳辉,李宗昌,贺莹,陈晓岗

DOI: https://doi.org/10.13479/j.cnki.jip.2018.04.004

2018-01-01

Abstract:Objective To explore cognitive function changes after risperidone monotherapy and their relationship to psychotic symptoms in treatment-na?ve first-episode schizophrenia patients. Methods We collected 42 treatmentna?ve patients with first-episode schizophrenia, and used Wisconsin Card Sorting Test (WCST), Digit Span Distraction Test (DSDT), Verbal Fluency Test (VFT), Stroop Color Word Test and Trail Marking Test (TMT) to explore their executive function, working memory and information processing speed. Positive and Negative Syndrome Scale (PANSS) was used to evaluate patients' symptoms at baseline and after treatment. Multiple regression analysis was utilized to compute the relation between cognitive deficits and symptoms. Results At baseline, WCST_perseverative errors of patients were significantly more than controls (P<0.001);the number of WCST_categories, DSDT_forward/backward and VFT was significantly less than controls (Ps<0.01). The time consumed in Stroop and TMT of patients was significantly more than that of controls (Ps<0.001). After treatment, patients' time consumed in Stroop_B and Stroop_C was significantly less than that at baseline, but there were no significant within-group differences in other cognitive performance. The worse of the performance in TMT_A/B, the more severe of patients' negative and total symptoms (Ps<0.05). The worse performance of the TMT_A at baseline, the less improvement of patients' positive symptoms (P=0.019). Conclusions Patients already have suffered from extensive cognitive impairments in their early episode. Patients' psychotic symptoms and information processing deficits can be improved after therapy, although their executive function and working memory are not improved. These imply that information processing deficits in patients may be state-biomarkers, but executive function and working memory impairments may be trait-biomarkers.
Negative symptoms in the clinical high‐risk state for psychosis: Connection with cognition and primacy in impacting functioning

Cory Gerritsen,Margaret Maheandiran,Jenny Lepock,Sarah Ahmed,Michael Kiang,Robert Michael Bagby,Romina Mizrahi

DOI: https://doi.org/10.1111/eip.12843

2019-07-02

Early Intervention in Psychiatry

Abstract:<h3 class="article-section__sub-title section1"> Aim</h3><p>In the clinical high‐risk (CHR) state for psychosis, both negative symptoms and lower cognitive function have been associated with poorer daily functioning. Recent evidence suggests that negative symptoms share overlapping variability with cognition and may partially mediate the relationship between cognition and functioning. However, the nature of this overlap is unknown, and the reverse mediation model remains untested leaving the precise nature of these associations unclear.</p><h3 class="article-section__sub-title section1"> Methods</h3><p>In order to clarify these relationships, a sample of community‐dwelling youth meeting CHR criteria was collected from a specialty CHR clinic (n = 91, mean age = 21, 63% male). Bootstrapping methods were then applied in a mediation analysis to test both negative symptoms and cognition as independent variables and mediating variables predicting social and role functioning in CHR individuals. Canonical correlation analysis was used to characterize the overlapping variability between negative symptoms and cognition.</p><h3 class="article-section__sub-title section1"> Results</h3><p>Support for a primary role of negative symptoms in predicting functioning and cognition was observed. Canonical correlation revealed a single dimension of overlap between the two symptom types (<i>r</i> = .62), represented by a strong correlation between negative symptoms in general and tasks involving verbal working memory, vigilance and social cognition specifically. A single cognitive factor composed primarily of these tasks was found to predict role functioning (adjusted <i>R</i><sup><i>2</i></sup> = .04). </p><h3 class="article-section__sub-title section1"> Conclusions</h3><p>The results highlight the importance of considering specific cognitive mechanisms overlapping with negative symptoms in research and rehabilitative practice in CHR populations, as well as the primary importance of targeting negative symptoms.</p>

psychiatry
Formal Thought Disorders and Neurocognition in Treatment-Resistant Schizophrenia: Trouble du cours de la pensée et neurocognition dans la schizophrénie réfractaire

Mohammed Alarabi,Leah Burton,Valerie Powell,Tanner Isinger,Sri Mahavir Agarwal,Gary Remington

DOI: https://doi.org/10.1177/07067437241293985

2024-11-07

The Canadian Journal of Psychiatry

Abstract:The Canadian Journal of Psychiatry, Ahead of Print. ObjectiveFormal thought disorders (FTDs), a core feature of schizophrenia, have been subdivided into positive and negative types, and are clinically assessed by examining speech (objective) or patient introspection (subjective). Despite being associated with poorer treatment response and worse outcomes, FTDs have been understudied in patients with schizophrenia, in particular treatment-resistant schizophrenia (TRS) or schizoaffective disorder. We aimed to explore the relationship between the severity of positive and negative FTDs and neurocognition as well as social/occupational functioning in this clinical subgroup.MethodThis was a retrospective chart review conducted at the Clozapine Clinic at the Centre for Addiction and Mental Health, Toronto, Canada. We reviewed charted standardized assessment of FTDs using the Thought and Language Disorder (TALD) scale, neurocognition using the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS), and functioning using the Social and Occupational Functioning Assessment Scale (SOFAS) between October 2022 and June 2023. Following the original factor structure of the TALD, we computed 4- factor scores that combined positive or negative and objective or subjective FTDs. We then explored the correlation between the scores from each TALD factor and the neurocognition and functioning scores.ResultsWe analysed data for 23 outpatients on clozapine. After the Bonferroni adjustment, total TALD scores, indicating overall severity of FTDs, were strongly and inversely correlated with SOFAS scores (p < 0.001). A strong inverse correlation was found between the objective positive TALD factor and Letter-Number Span verbal working memory scores, r(21) = −0.63, p < 0.001.ConclusionsOur results demonstrate the strong relationship between FTDs, neurocognition, and social/occupational functioning in a sample of TRS outpatients. Within the cognitive domains assessed, verbal working memory impairment had the strongest correlation with positive FTDs, such as derailment or tangentiality. These findings highlight the value of employing standardized psychopathological scales for FTDs in clinical practice.

psychiatry
Abnormal hedonic process in patients with stable schizophrenia: Relationships to negative symptoms and social functioning

Qi Zhou,Yue Zheng,Xiaodong Guo,Yi Wang,Chengcheng Pu,Chuan Shi,Xin Yu

DOI: https://doi.org/10.1016/j.scog.2024.100325

2024-08-24

Abstract:Background: Anhedonia is a deficit of dynamic reward process, and a large proportion of schizophrenia patients continue to experience anhedonia even during the stable phase. However, few studies have examined the multiple aspects of performance in reward processing in patients with stable schizophrenia and evidence suggests that physical and cognitive effort may involve different neural mechanisms. Methods: Parallel measures of effort-based expenditure for reward tasks (EEfRT) and self-report questionnaires of pleasure were applied in 61 patients with stable schizophrenia (SSZ) and 46 healthy controls (HCs), and percentages of hard task choices (HTC%) were used to assess motivation in reward processing. Negative symptoms, neurocognitive and social function were evaluated in SSZ patients, and associations with performance in reward tasks were explored. Results: SSZ patients reported more severe consummatory and anticipatory anhedonia and social anhedonia. HTC% in reward tasks of SSZ patients were significantly lower than that of HCs, especially in cognitive-effort tasks. HTC% in cognitive tasks were correlated with motivation and pleasure dimension of negative symptoms, whereas HTC% in physical tasks were associated with expression dimension. Anticipatory anhedonia and negative symptoms were correlated with Personal and Social Performance Scale (PSP) scores. Conclusion: Patients with stable schizophrenia have social anhedonia, physically consummatory and anticipatory anhedonia and reduced reward motivation. They are less willing to make cognitive effort than physical effort for reward. The different associations of physical and cognitive effort with negative symptoms indicate physical and cognitive effort may represent disparate neuropsychological processes. Anticipatory anhedonia is closely related to social functioning.
Die Vestibulotomie als hörverbessernde Operation

K. Schubert

DOI: https://doi.org/10.1007/BF02102563

Archiv für Klinische und Experimentelle Ohren- Nasen- und Kehlkopfheilkunde

Abstract:
Psychometric assessment of patients with treatment-resistant schizophrenia

V. Kaleda,D. Tikhonov

DOI: https://doi.org/10.1192/j.eurpsy.2024.1560

2024-08-30

European Psychiatry

Abstract:Introduction Treatment-resistant schizophrenia (TRS) is one of the most pressing issues in the field of treatment and research of psychotic disorders. The pronounced decline in social and professional functioning in this group of patients as well as high costs of therapy determine high interest in TRS. This is a part of an ongoing study on the clinical and biological features of TRS. Objectives The aim of this study is to identify the leading symptoms in patients with TRS. Methods Using the Personal and Social Performance Scale (PSP), Positive and Negative Syndrome Scale (PANSS) and Calgary Depression Scale for schizophrenia (CDSS), 30 male patients (age 28.99 ± 8.08 years) diagnosed with paranoid schizophrenia (F20.0) were examined. All patients had persistent productive symptoms and met the criteria for TRS. The average daily doses of antipsychotics in chlorpromazine equivalent were 1382.07 ± 897.15 mg/day. The average age of onset of the disease was 19.52 ± 5.97 years, the average disease was 9.47 ± 7.61 years. Results The average scores were: on the PSP scale: 46.05 ± 9.17, on the CDSS scale 8.10 ± 4.53, on the PANSS positive symptoms subscale - 21.52 ± 4.24, on the PANSS negative symptoms subscale - 24.67 ± 4.42, on the general psychopathology subscale PANSS – 45.62 ± 6.11 . Positive symptoms were represented mainly by delusions (P1, 4.14 ± 0.85 points) and hallucinations (P3, 4.10 ± 1.76 points). Blunted affect (N1, 4.29 ± 0.56 points) and emotional withdrawal (N2, 3.67 ± 0.73 points) predominated among negative symptoms, while the least prominent negative symptom was poor rapport (N3, 3.24 ± 0.94). The most pronounced general psychopathology symptoms were depression (G6, 4.00 ± 1.10 ) and lack of judgment and insight (G12, 4.05 ± 0.92). The total score on the PANSS was 91.81 ± 12.40. Conclusions The CDSS score indicates a high incidence of depressive symptoms in patients with TRS. A low PSP score reflects poor social functioning. The most common symptoms according to the PANSS are delusions, hallucinations, blunted affect, emotional withdrawal, depression and lack of judgment and insight. Disclosure of Interest None Declared

psychiatry
[Colostrum intake and immunoglobulin absorption by calves with and without birth acidosis].

U. Eigenmann,W. Zaremba,K. Luetgebrune,E. Grunert

1983-04-01

Abstract:
The Negative Symptoms of Schizophrenia: A Cognitive Perspective

Neil A Rector,Aaron T Beck,Neal Stolar

DOI: https://doi.org/10.1177/070674370505000503

2005-04-01

The Canadian Journal of Psychiatry

Abstract:Recent reports of improvement in the negative symptoms of schizophrenia following targeted cognitive interventions have prompted interest in the cognitive underpinnings of these symptoms. This review integrates current experimental research with the phenomenological accounts of patients participating in cognitive therapy for these specific symptoms. We propose that, in addition to the well-established role of neurobiological factors in their development and maintenance, specific cognitive appraisals and beliefs play a role in the expression and persistence of negative symptoms. This cognitive model of negative symptoms is based on a diathesis–stress formulation: a continuum of predispositional traits from the premorbid personality to the full-blown negative symptomatology, the incorporation of negative social and performance attitudes within these traits, and low expectancies for pleasure or success in goal-oriented activities. We suggest that negative symptoms represent, in part, a compensatory pattern of disengagement in response to threatening delusional beliefs, perceived social threat, and anticipated failure in tasks and social activities. A psychological aspect of this motivational and behavioural inertia appears to be the patient's perception of limited psychological resources—a perception that motivates patients to conserve energy by minimizing investment in activities requiring effort.

Carlos F. Salinas, DMD (April 9, 1941–January 14, 2015)

Predictors of functioning in treatment-resistant schizophrenia: the role of negative symptoms and neurocognition

Increased Sensitivity to Effort and Perception of Effort in People with Schizophrenia

Association between treatment resistance and cognitive function in schizophrenia

Reward-dependent modulation of working memory is associated with negative symptoms in schizophrenia

Dampened motivation in schizophrenia: evidence from a novel effort-based decision-making task in social scenarios

Implicit cognitive effort monitoring impairments are associated with expressive negative symptoms in schizophrenia

Different Lifestyles and their Impact on the Environment

Shifting the focus toward rare variants in schizophrenia to close the gap from genotype to phenotype

Relationship of Behavioural and Symptomatic Syndromes in Schizophrenia to Spatial Working Memory and Attentional Set-Shifting Ability

Heterogeneity analysis of diffusion-weighted MRI for prediction and assessment of microstructural changes early after one cycle of induction chemotherapy in nasopharyngeal cancer patients

Failure of convulsive response in electroconvulsive therapy in a patient treated with acetazolamide (diamox); report of a case.

S67. TREATMENT-RESISTANCE AFFECTS LONG-TERM COGNITIVE TRAJECTORIES IN SCHIZOPHRENIA: A LONGITUDINAL STUDY

Cognitive function changes with risperidone monotherapy and their relationship to psychotic symptoms in treatment-na?ve first-episode schizophrenia patients

Negative symptoms in the clinical high‐risk state for psychosis: Connection with cognition and primacy in impacting functioning

Formal Thought Disorders and Neurocognition in Treatment-Resistant Schizophrenia: Trouble du cours de la pensée et neurocognition dans la schizophrénie réfractaire

Abnormal hedonic process in patients with stable schizophrenia: Relationships to negative symptoms and social functioning

Die Vestibulotomie als hörverbessernde Operation

Psychometric assessment of patients with treatment-resistant schizophrenia

[Colostrum intake and immunoglobulin absorption by calves with and without birth acidosis].

The Negative Symptoms of Schizophrenia: A Cognitive Perspective